If the estimated true prevalence falls outside the 0 to 1 range, what does this indicate?

Study for the ACVPM Epidemiology and Biostatistics Exam. Prepare with flashcards and multiple choice questions, with hints and explanations for each. Be exam-ready!

Multiple Choice

If the estimated true prevalence falls outside the 0 to 1 range, what does this indicate?

Explanation:
When you adjust a measured apparent prevalence for an imperfect diagnostic test, the resulting true prevalence should be a proportion between 0 and 1. This makes sense because prevalence is, by definition, the fraction of the population that truly has the condition. The math behind this is that true prevalence is derived from the apparent prevalence using the test’s sensitivity and specificity. If the calculation yields a value outside 0–1, it means the sensitivity and specificity being used do not apply to the study population. In other words, the test performance estimates are not appropriate for this setting (they may be affected by spectrum differences, different disease definitions, or errors in the assumed test characteristics), so the adjusted prevalence can’t be trusted. So the best interpretation is that the sensitivity and specificity estimates aren’t applicable for this population. The other options don’t capture the underlying issue as precisely: a small sample affects precision, not feasibility of the estimate; a perfect test would still produce a valid 0–1 prevalence; and saying no interpretation is possible is too vague compared to identifying incompatible test characteristics.

When you adjust a measured apparent prevalence for an imperfect diagnostic test, the resulting true prevalence should be a proportion between 0 and 1. This makes sense because prevalence is, by definition, the fraction of the population that truly has the condition.

The math behind this is that true prevalence is derived from the apparent prevalence using the test’s sensitivity and specificity. If the calculation yields a value outside 0–1, it means the sensitivity and specificity being used do not apply to the study population. In other words, the test performance estimates are not appropriate for this setting (they may be affected by spectrum differences, different disease definitions, or errors in the assumed test characteristics), so the adjusted prevalence can’t be trusted.

So the best interpretation is that the sensitivity and specificity estimates aren’t applicable for this population. The other options don’t capture the underlying issue as precisely: a small sample affects precision, not feasibility of the estimate; a perfect test would still produce a valid 0–1 prevalence; and saying no interpretation is possible is too vague compared to identifying incompatible test characteristics.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy